Trial Profile
Randomized, double-blind, active-controlled, superiority trial to study effect of high dose Fimasartan on changes of daytime and nighttime Blood Pressure compared to high dose Valsartan
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jul 2018
Price :
$35
*
At a glance
- Drugs Fimasartan (Primary) ; Valsartan
- Indications Hypertension
- Focus Therapeutic Use
- 28 Jul 2018 New trial record
- 11 Jun 2018 Results of superiority trial presented at the 28th European Meeting on Hypertension and Cardiovascular Protection.